According to the article The mechanism and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhea there is a great concern about increasing incidence of C. difficile infection due to use of broad spectrum antibiotics. Clindamycin, third generation of cephalosporins and flouroquinolones are considered high risk antibiotics. It is believed that normal gastrointestinal flora has potential effect in inhibition C.difficile growth and toxin A,B release which offen associated with sever diarrhea resulting in patient’s mortality and other comorbidities. After first episode, there is a high chance for relapses due to reduction serum IgG antibodies to toxin A and colonic IgA secretion cells. Metronidazole and vancomycin are indicated for treatment of C.difficile and two studies in animal model suggest that use of culture-specific probiotics, such as S. boulardii can up-regulate anti-toxin a secretary IgA. According to one large study, well-designed study A Randomized Placebo-Controlled Trial of Saccharomyces Boulardii in Combination with Standard Antibiotics f...
Clostridium difficile, otherwise known as C. diff, is a species of spore-forming, anaerobic, gram-positive bacteria that is known to cause watery diarrhea. 1 The genus name, Clostridium refers to the spindle shape of the organism while Difficile means difficult in Latin due to the fact that this organism thrives in unfavorable conditions and is very difficult to isolate.4 The incidence of getting CDI has increased over the years due to new strains of increased toxin production of the bacteria and increased resistance to antibiotics.2 It is a gastrointestinal infection, and the most common cause of infectious diarrhea.1 C. difficile was first identified in the feces of healthy newborns back in the 1930’s and by 1935, it was considered normal flora. 2 During 1974, researchers conducted that about 21% of patients that were treated with an antibiotic called clindamyacin reported diarrhea and about 10% of them reported to have conducted pseudomembranous colitis as a side effect of this treatment. 2 It was in 1978 where C. diff had been known to cause anti-biotic associated diarrhea and pseudomembranous colitis. 2 It is known to form spores that resist many disinfectants; it also survives for several months on different surfaces.1 It is a common form of a nosocomial infection and the prevalence of becoming infected with C. diff is about 0-15% in a health care setting. 3 The spores survive well in environments such as soil, water and animals and is distributed worldwide. 4 CDI produces two toxins (Toxin A and B), which are cytotoxic and cause tissue necrosis.4
Verma P, Chandrakar V, Chitra (2012) Antibiotic sensitivity treatment for gram negative bacteria isolated from pus sample. Int. J. Pharm Biol Sci. 2( 3): 359-363.
A common hospital acquired condition that nurses see now days is clostridium difficile. This bacterium usually invades patients who have been on long-term antibiotics that have killed off bacteria that protect them from infection. C. diff is passed from host to host by both direct and indirect contact making it readily moved from patient to patient in hospital settings (Mayo, 2013, 1). Nurses can use the QSEN competencies and KSAs to help treat and prevent hospital acquired conditions such as C.diff.
Clostridium difficile infection usually occurs in people who are being treated with broad-spectrum antibiotics. The antibiotics kill all of the normal flora in the intestines leaving no bacteria to compete with C. difficile. It is then able to colonize and proliferate. It releases Toxin A and Toxin B. Toxin A is an ent...
An Evolving Epidemic Head scientist at the antibiotic research center at McMaster University in Hamilton, Ohio, Gerry Wright, has studied the genes of 500 streptomyces strains, a type of bacteria, many of which had never previously been identified. All 500 strains held antibiotic-resistance genes and on average were resistant to 8 of 21 tested antibiotics (Sachs). With an average resistance rate as high as 67 percent in some of these streptomyces species, it is evident that antibiotic resistance is a rising problem. Regardless of the countless studies proving antibiotic resistance and articles about the subject, it is one the public knows little about. With such a history of antibiotic benefits, it is difficult to perceive the negative effects these drugs have.
The significant increase in antibiotic resistance amongst pathogens is making it very difficult to successfully treat infections, especially in intensive care units (ICU’s). Prevention of the spread of infection among patients within the hospitals is fast becoming amongst the most important methods for controlling infections. This requires the identification of the different acquisition routes, that is, routes by which bacterial colonization occurs. In this article, the authors analyzed the relative importance of various bacterial acquisition routes that resulted in colonization of the bacteria using data from individual patients.[1] This article was chosen because of the impact it can have on the healthcare system if the knowledge obtained from the algorithm regarding the most prevalent colonization routes in hospitals can help in the preventing spread of infections. Also the ability of the algorithm to incorporate specific patient characteristics makes it both novel and appealing.
In addition to the ability of eliminating bacteria similar to antibiotics, HDPs can also naturalize endotoxin produced by gram-negative bacteria, thereby limiting the inflammatory reaction in host [7]. Moreover, with the difference of mechanisms comparing to antibiotics, HDPs will cause less toxicity toward host cells and have a low risk of microbial resistance [8]. HDPs can be induced by various factors. Rather than pathogens, some dietary resources such as fatty acids, histone deacetylase (HDAC) inhibitor, curcumin, vitamin D3, zinc, and disaccharides were reported to have HBD1 and LL37 induction activities, thereby boosting HDPs [3,9-11]. Those results capacitated the therapeutic possibility of HDPs-inducing drug and treatment.
Is fecal microbiota transplant (FMT) effective treatment for patients with Ulcerative Colitis (UC). UC is a chronic inflammation of the large intestine. FMT is used to describe the delivery of a healthy donors stool into a patient via enema, colonoscope, or nasogastric tube. In the past several years FMT has been used for an alternative treatment with patients diagnosed with Clostridium difficile (CD). The purpose of this paper is to discuss if FMT is just as effective in treating UC over just medication. The articles below will give insight if this theory is true or not.
applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 168(2013), 75-79. doi: 10.1016/j.ejogrb.2012.12.031p
The purpose of this paper is to review and summarize an article concerning antibiotic resistance. The article chosen was “The role of healthcare strategies in controlling antibiotic resistance” by Ann-Marie Aziz (2013) published in British Journal of Nursing, Vol. 22 Issue 18. This article discusses essential components to understand how antibiotics work; different strains of bacteria; what antibiotic resistance means and consists of; antibiotic resistance when pertaining to the production of foods. Along with strategies that can be utilized in health care to help reduce antibiotic resistance. For example, prescribing adjustments, sampling and testing; committees and education for staff and patients.
... antibiotic resistance has quickly become an increasing concern in recent times due to the growing use of antibiotics. To combat this problem, we propose that healthy intestinal floras be maintained after antibiotic resistance using fecal bacteriotherapy, and that processes of lateral gene transfer be disrupted before antibiotic resistance through the use of copper surfaces and after antibiotic resistance through synthesized CSPs. Continuing research in these solutions as well as implementing these strategies into mainstream medicine will certainly reduce the frequency of antibiotic resistance along with incidences of serious disease outbreaks in hospitals. With a better understanding of the causes of antibiotic resistance and the role that patients and doctors play in these causes, it is time to move forward and attempt to eradicate this problem once and for all.
C. difficile infection (CDI) is a dangerous healthcare-associated infection as well as a growing burden, especially with the appearance of more potent strains in the early 2000s. Clostridium difficile was initially identified as possessing the ability to initiate pseudomembranous colitis in the late 1970s. Asymptomatic colonization in healthy adults has been detected in only 3% of individuals, whereas the pervasiveness of such colonization among patients in long-term-care facilities is approximately 50%. People colonized with C. difficile act as a reservoir of contamination by infecting the environment with C. difficile spores, consequently leading to an increase of the pathogen on the hand...
Examine the ways that health professionals can use five steps of evidence based practice (EBP) as a practical framework to overcoming barriers to locating, appraising, and applying the best research evidence to an occupational health and safety practice.
Infection control is very important in the health care profession. Health care professionals, who do not practice proper infection control, allow themselves to become susceptible to a number of infections. Among the most dreaded of these infections are: hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV). Another infection which has more recently increased in prevalence is methicillin-resistant Staphylococcus aureus (MRSA). These infections are all treated differently. Each infection has its own symptoms, classifications, and incubation periods. These infections are transmitted in very similar fashions, but they do not all target the same population.
When antibiotics first began to see widespread American usage in the 1940’s, they were heralded as a miracle drug, a description that was not far from the mark considering the great number of debilitating or fatal illnesses that they could rapidly cure. In a time where bacterial diseases that today carry few serious health risks in healthy adults—such as strep throat, ear infections, syphilis, and wound infections—often led to serious debilitation or death, the invention of antibiotics was among the greatest single improvements in public health ever made. And today, more than three quarters of a century after Alexander Fleming discovered the antimicrobial properties of penicillin, antibiotics are as important as ever in maintaining a healthy population, from their ability to treat common infections to the safeguards they provide patients undergoing surgeries and other infection-prone procedures that could otherwise be too risky to perform. However, today many doctors and researchers are beginning to fear that this golden era of antibiotics may be coming to an end due to the ever-increasing threat of antibiotic resistance. There are a number of practices that contribute to increased antibiotic resistance, including the unnecessary prescription, improper dosage, and incorrect usage of antibiotic drugs by humans. But one of the major potential causes of antibiotic resistance does not involve human patients at all. Rather, many believe that the excessive use of antibiotics in food animals is among the leading threats to the future of human ability to fight bacterial infections.